References
- Measles WHO. A strategic framework for the elimination of measles in the European Region. The Expanded Programme on Immunization in the European Region of WHO (1999) Copenhagen. http://www.euro.who.int/__data/assets/pdf_file/0003/119802/E68405.pdf. Accessed 12 October 2012.
- World Health Organization. Eliminating measles and rubella and preventing congenital rubella infection. WHO European Region strategic plan 2005-2010 (2005) Copenhagen: WHO Regional Office For Europe. http://www.euro.who.int/document/E87772.pdf. Accessed 12 October 2012.
- Nardone A, Pebody RG, van den Hof S, Levy-Bruhl D, Plesner AM, Rota MC, et al. Sero-epidemiology of mumps in western Europe. Epidemiol Infect 2003; 131:691 - 701; http://dx.doi.org/10.1017/S0950268803008768; PMID: 12948369
- de Madrid C. Dirección General de Salud Pública y Alimentación. Vacunación frente a rubeola en mujeres en edad fértil. Control del síndrome de rubeola congénita. http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-disposition&blobheadername2=cadena&blobheadervalue1=filename%3DDOCUMENTO_TECNICO_RUBEOLA.pdf&blobheadervalue2=language%3Des%26site%3DPortalSalud&blobkey=id&blobtable=MungoBlobs&blobwhere=1271649994128&ssbinary=true.Accessed 10 September 2012.
- Community of Madrid. Report on the health status of the population of the Community of Madrid 2009. http://www.madrid.org/cs/Satellite?cid=1142588809240&language=es&pagename=PortalSalud%2FPage%2FPTSA_pintarContenidoFinal&vest=1161769238915. Accessed 14 April 2013.
- Tagarro García A, Jiménez Bueno S, Herreros Fernández ML, Santiago García B, González Gil I, Baquero-Artigao F, et al. [Outbreak of measles in the population of Spanish origin in North Madrid]. An Pediatr (Barc) 2012; 76:350 - 4; PMID: 22265376
- EUVAC. Net. ECDC measles and rubella monitoring (EMMO) http://ecdc.europa.eu/en/publications/Publications/2012June13_SUR_measles_rubella_report.pdf. Accessed 24 March 2013.
- National Epidemiology Center. Health Institute Carlos III. Annual report of the plan for eliminating measles, rubella, and congenital rubella syndrome in Spain 2010.http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/fd-enfermedades-prevenibles-vacunacion/Informe-Anual-Plan-Eliminacion-del-Sarampion-Rubeola-y-Sindrome-de-Rubeola-Congenita-Espana-2010.pdf.Accessed 10 april 2013.
- Cardeñosa Marín N. [Seroepidemiologic studies]. Rev Esp Salud Publica 2009; 83:607 - 10; http://dx.doi.org/10.1590/S1135-57272009000500017; PMID: 20111809
- III Serosurveillance Survey of the community of Madrid (2002). Bol Epidemiol Comunidad Madrid; 8:3-41 http://www.madrid.org/cs/Satellite?blobtable=MungoBlobs&blobcol=urldata&blobkey=id&blobheadervalue1=filename%3Dmayo2002.pdf&blobwhere=1119142927576&blobheadername1=Content-Disposition&ssbinary=true&blobheader=application%2Fpdf. Accessed 22 April 2013.
- National Epidemiology Center. Health Institute Carlos III (2000) Seroepidemiological Study: Status of vaccine-preventable diseases in Spain. Health Institute Carlos III. http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/SEROEPIDEMIOLOGICO.pdf. Accessed 22 April 2013.
- Guillen JM, Gil-Prieto R, Alvaro A, Gil A. Burden of adult varicella hospitalizations in Spain (2001-2007). Hum Vaccin 2010; 6:659 - 63; http://dx.doi.org/10.4161/hv.6.8.12014; PMID: 20523119
- Tos ferina [Pertussis]. Bol Epidemiol Comunidad de Madrid. 2008; 11:39-49. http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-disposition&blobheadername2=cadena&blobheadervalue1=filename%3DNoviembre2008.pdf&blobheadervalue2=language%3Des%26site%3DPortalSalud&blobkey=id&blobtable=MungoBlobs&blobwhere=1220585963986&ssbinary=true Accessed 22 April 2013.
- Tischer A, Andrews N, Kafatos G, Nardone A, Berbers G, Davidkin I, et al. Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect 2007; 135:787 - 97; http://dx.doi.org/10.1017/S0950268807008266; PMID: 17394675
- Sanz Moreno JC, García Comas L, Ramírez Fernández R, Ramos Blázquez B, Ordobás Gavín M. [Evolution of measles, rubella and mumps from the third seroepidemiological survey in the autonomous region of Madrid, Spain]. Rev Esp Salud Publica 2009; 83:625 - 37; PMID: 20111811
- Community of Madrid. Report on epidemiological surveillance 2007-2010. Measles, rubella and congenital rubella syndrome. http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Contentdisposition&blobheadername2=cadena&blobheadervalue1=filename%3DSAR_RUB_2007_10.pdf&blobheadervalue2=language%3Des%26site%3DPortalSalud&blobkey=id&blobtable=MungoBlobs&blobwhere=1310786570627&ssbinary=true. Accessed 22 April 2013.
- Amela C, Pachón I, de Ory F. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Eur J Epidemiol 2003; 18:71 - 9; http://dx.doi.org/10.1023/A:1022567811765; PMID: 12705626
- Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 2004; 132:11 - 8; http://dx.doi.org/10.1017/S0950268803001584; PMID: 14979584
- Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, et al. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect 2011; 139:494 - 504; http://dx.doi.org/10.1017/S0950268810001536; PMID: 20587123
- Domínguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, et al. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 2006; 25:310 - 7; http://dx.doi.org/10.1007/s10096-006-0133-z; PMID: 16786377
- Matter L, Kogelschatz K, Germann D. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. J Infect Dis 1997; 175:749 - 55; http://dx.doi.org/10.1086/513967; PMID: 9086126
- Nardone A, Tischer A, Andrews N, Backhouse J, Theeten H, Gatcheva N, et al. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ 2008; 86:118 - 25; http://dx.doi.org/10.2471/BLT.07.042010; PMID: 18297166
- Hernández Díaz R, Rodrigo Val MP, Misiego Peral A, Roc Alfaro ML, Adiego Sancho MB. [Seroepidemiologic study of rubella in childbearing women in Aragon, Spain (2003-2007)]. Gac Sanit 2011; 25:20 - 2; PMID: 21074904
- Garrido Álvarez E, Álvarez Pasquín MJ, Gómez Marco J, Martín Martín S, Kloppe Villegas P, Hernando López T. Seroprevalence of antibodies against rubella in female immigrants of childbearing age in two health centres in Madrid. Vacunas 2004; 5:75 - 8
- Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?. Epidemiol Infect 2012; 12:1 - 16; PMID: 22687578
- Gabutti G, Guido M, Rota MC, De Donno A, Ciofi Degli Atti ML, Crovari P, Seroepidemiology Group. The epidemiology of mumps in Italy. Vaccine 2008; 26:2906 - 11; http://dx.doi.org/10.1016/j.vaccine.2008.03.040; PMID: 18439732
- National Epidemiology Center. Institute of Health Carlos III. (2006) Status of varicella in Spain (2006). http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/fd-enfermedades-prevenibles-vacunacion/InformevaricelaCNE.pdf. Accessed 17 April 20123.
- Peña-Rey I, Martínez de Aragón MV, Villaverde Hueso A, Terres Arellano M, Alcalde Cabero E, Suárez Rodríguez B. [Epidemiology of varicella in spain pre-and post-vaccination periods]. Rev Esp Salud Publica 2009; 83:711 - 24; PMID: 20111819
- Clements DA, Zaref JI, Bland CL, Walter EB, Coplan PM. Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med 2001; 155:455 - 61; PMID: 11296072
- Salleras L, Domínguez A, Plans P, Costa J, Cardeñosa N, Torner N, et al. Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol 2008; 197:329 - 33; http://dx.doi.org/10.1007/s00430-007-0064-z; PMID: 18004592
- Chris Maple PA, Gunn A, Sellwood J, Brown DW, Gray JJ. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals. J Virol Methods 2009; 155:143 - 9; http://dx.doi.org/10.1016/j.jviromet.2008.09.032; PMID: 18996415
- Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25:7866 - 72; http://dx.doi.org/10.1016/j.vaccine.2007.07.036; PMID: 17919788
- Domínguez A, Vidal J, Plans P, Salleras L. The seroepidemiology of B. pertussis infection in Catalonia, Spain. Epidemiol Infect 2001; 126:205 - 10; http://dx.doi.org/10.1017/S0950268801005325; PMID: 11349970
- García-Corbeira P, Dal-Ré R, Aguilar L, García-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000; 18:2173 - 6; http://dx.doi.org/10.1016/S0264-410X(00)00029-3; PMID: 10717335
- de Juanes JR, Gil A, González A, Arrazola MP, San-Martín M, Esteban J. Seroprevalence of pertussis antibody among health care personnel in Spain. Eur J Epidemiol 2004; 19:69 - 72; http://dx.doi.org/10.1023/B:EJEP.0000013270.63515.e6; PMID: 15012025
- Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996; 173:1256 - 9; http://dx.doi.org/10.1093/infdis/173.5.1256; PMID: 8627081
- Rendi-Wagner P, Tobias J, Moerman L, Goren S, Bassal R, Green M, et al. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection. Vaccine 2010; 28:3285 - 90; http://dx.doi.org/10.1016/j.vaccine.2010.02.104; PMID: 20226250
- Quinn HE, McIntyre PB, Backhouse JL, Gidding HF, Brotherton J, Gilbert GL. The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiol Infect 2010; 138:426 - 33; http://dx.doi.org/10.1017/S0950268809990707; PMID: 19719902
- Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010; 48:4459 - 63; http://dx.doi.org/10.1128/JCM.01371-10; PMID: 20943873
- Xing D, Markey K, Newland P, Rigsby P, Hockley J, He Q. EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis. J Immunol Methods 2011; 372:137 - 45; http://dx.doi.org/10.1016/j.jim.2011.07.005; PMID: 21782823
- Wirsing von König CH, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005; 24:Suppl S87 - 92; http://dx.doi.org/10.1097/01.inf.0000160920.75623.a3; PMID: 15876934